Utilizzo delle immunoglobuline endovenose nella pratica clinica in pediatria

Translated title of the contribution: Intravenous immunoglobuline in paediatrics

Giovanna Ventura, Marco Rabusin, Elena Spinelli, Raffaele Badolato

Research output: Contribution to journalArticlepeer-review

Abstract

Intravenous immunoglobuline is a blood product prepared from the serum of between 1,000 and 15,000 donors per batch. It is the treatment indicated for patients with antibody deficiencies and it is used in replacement doses of 200-400 mg/kg. In contrast, high IVIg doses generally given at 2 g/kg are used as immunomodulatory agent in an increasing number of immune and inflammatory disorders such as: immune thrombocytopenic purpura, Kawasaki syndrome, dermatomyositis, toxic epidermal necrolysis, autoimmune neurological diseases as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, and post bone marrow transplantation. In the paper the Authors review recent development in the understanding of the mechanism of action of IVIg, the major current clinical applications and the most common side effects.

Translated title of the contributionIntravenous immunoglobuline in paediatrics
Original languageItalian
Pages (from-to)371-381
Number of pages11
JournalMedico e Bambino
Volume28
Issue number6
Publication statusPublished - Jun 2009

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Intravenous immunoglobuline in paediatrics'. Together they form a unique fingerprint.

Cite this